| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 PRPF8 USP17L6P TNFAIP3 USP17L22 USP17L15 USP17L8 | 1.34e-19 | 124 | 243 | 22 | GO:0101005 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P TNFAIP3 USP17L22 USP17L15 USP17L8 | 4.08e-19 | 114 | 243 | 21 | GO:0004843 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 PRPF8 USP17L6P TNFAIP3 USP17L22 USP17L15 USP17L8 | 1.28e-18 | 137 | 243 | 22 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 CLC USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P TNFAIP3 USP17L22 USP17L15 USP17L8 | 2.02e-15 | 192 | 243 | 22 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 PHEX CLC USP17L17 USP32 USP17L3 MMP7 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 PRPF8 USP17L6P TNFAIP3 USP17L22 USP17L15 USP17L8 | 4.64e-07 | 654 | 243 | 25 | GO:0008233 |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 6.96e-07 | 15 | 243 | 5 | GO:0005005 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 2.59e-06 | 19 | 243 | 5 | GO:0005003 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 9.01e-06 | 24 | 243 | 5 | GO:0017075 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.90e-05 | 46 | 243 | 6 | GO:0005245 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.95e-05 | 14 | 243 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYO5A SPTAN1 SRY RYR3 ASPM EEF2K UNC13B CACNA1A CACNA1S GRM7 UNC13C UNC13A | 2.66e-05 | 230 | 243 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 6.01e-05 | 7 | 243 | 3 | GO:0005004 | |
| GeneOntologyMolecularFunction | syntaxin binding | 9.26e-05 | 87 | 243 | 7 | GO:0019905 | |
| GeneOntologyMolecularFunction | actin filament binding | MYO5A SPTAN1 NEB SVIL EPS8L3 FERMT2 MICAL1 NRAP SYNE1 ACTR2 SIPA1L1 | 1.11e-04 | 227 | 243 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | recombination hotspot binding | 1.47e-04 | 2 | 243 | 2 | GO:0010844 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 1.47e-04 | 2 | 243 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 1.47e-04 | 2 | 243 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SIPA1L1 | 1.68e-04 | 279 | 243 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | calcium channel activity | 1.84e-04 | 129 | 243 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 5.34e-04 | 151 | 243 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | actin binding | MYO5A SPTAN1 NEB PTK2 SVIL EPS8L3 CORO7 FERMT2 MICAL1 NRAP SYNE1 DYRK1A ACTR2 PFN3 SIPA1L1 | 8.22e-04 | 479 | 243 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | galactosyltransferase activity | 8.33e-04 | 35 | 243 | 4 | GO:0008378 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | GLT8D1 GBE1 TMTC2 C1GALT1C1L GXYLT1 COLGALT1 TMTC1 B3GNT2 WDFY3 GALNT6 HAS2 | 8.44e-04 | 288 | 243 | 11 | GO:0016757 |
| GeneOntologyMolecularFunction | oxoglutarate dehydrogenase (succinyl-transferring) activity | 8.71e-04 | 4 | 243 | 2 | GO:0004591 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 8.87e-04 | 16 | 243 | 3 | GO:0019992 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | GBE1 TMTC2 C1GALT1C1L COLGALT1 TMTC1 B3GNT2 WDFY3 GALNT6 HAS2 | 1.16e-03 | 211 | 243 | 9 | GO:0016758 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.17e-03 | 65 | 243 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | SNARE binding | 1.40e-03 | 136 | 243 | 7 | GO:0000149 | |
| GeneOntologyMolecularFunction | kinase binding | MYO5A SHC3 PTK2 GHR NEFH WWC2 KIDINS220 PIK3R2 CLTC PLCG2 FERMT2 GOLGA2 PITPNM2 PRKD2 MICAL1 SRSF5 JAKMIP3 CDK5RAP3 SIPA1L1 EIF3A TNFAIP3 MAPK9 EPHA4 | 1.76e-03 | 969 | 243 | 23 | GO:0019900 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO5A SPTAN1 NEB PTK2 NEFH SVIL CLTC EPS8L3 HOOK2 CORO7 FERMT2 HSPA2 GOLGA2 RANBP10 MICAL1 NRAP SYNE1 DYRK1A JAKMIP3 ACTR2 PFN3 KIF7 SIPA1L1 MARK4 UNC13A | 2.00e-03 | 1099 | 243 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.02e-03 | 145 | 243 | 7 | GO:0004713 | |
| GeneOntologyMolecularFunction | chitinase activity | 2.14e-03 | 6 | 243 | 2 | GO:0004568 | |
| GeneOntologyMolecularFunction | quaternary ammonium group binding | 2.34e-03 | 46 | 243 | 4 | GO:0050997 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P TNFAIP3 USP17L22 USP17L15 USP17L8 | 1.33e-18 | 125 | 241 | 21 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P TNFAIP3 USP17L22 USP17L15 USP17L8 | 2.74e-17 | 144 | 241 | 21 | GO:0070646 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SIPA1L1 | 5.68e-09 | 109 | 241 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L21 KLHDC2 USP17L20 USP17L19 TTC3 BIRC6 USP17L18 USP17L17 USP32 USP17L3 MED23 HERC6 FEM1A USP17L13 ATG5 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 CDC14B CDK5RAP3 USP17L6P TNFAIP3 MAPK9 USP17L22 HERC4 USP17L15 RPL11 USP17L8 TRIM51G | 2.72e-08 | 1009 | 241 | 34 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L21 KLHDC2 USP17L20 USP17L19 TTC3 BIRC6 USP17L18 USP17L17 USP32 USP17L3 MED23 HERC6 FEM1A USP17L13 ATG5 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 CDC14B VIPAS39 CDK5RAP3 USP17L6P TNFAIP3 MAPK9 USP17L22 HERC4 USP17L15 RPL11 USP17L8 TRIM51G | 3.80e-08 | 1074 | 241 | 35 | GO:0043687 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | PTK2 TBC1D3I FERMT2 TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 USP17L2 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SIPA1L1 EPHA3 EPHA4 EPHA5 | 9.08e-08 | 335 | 241 | 18 | GO:0043087 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | EPHB2 ATP7A KIDINS220 EEF2K CACNA1A CACNA1F SYNE1 ZNF365 ACTR2 SIPA1L1 EPHA4 EPHA5 EPHB1 | 6.26e-07 | 198 | 241 | 13 | GO:0048813 |
| GeneOntologyBiologicalProcess | dendritic spine organization | EPHB2 ITGA3 ZNF804A EEF2K ZNF365 ACTR2 SIPA1L1 EPHA4 EPHA5 EPHB1 | 1.00e-06 | 115 | 241 | 10 | GO:0097061 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3I FERMT2 TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 USP17L2 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SIPA1L1 | 1.17e-06 | 244 | 241 | 14 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPHB2 ATP7A HLA-H ITGA3 TTC3 ZNF804A PTK2 KIDINS220 WASHC5 WRAP73 EEF2K EPS8L3 GOLGA2 ATG5 CACNA1A TBC1D3 USP17L2 SYNE1 ZNF365 ACTR2 TENM3 SIPA1L1 MARK4 TENM1 LRP6 EPHA3 EPHA4 | 2.34e-06 | 846 | 241 | 27 | GO:0120035 |
| GeneOntologyBiologicalProcess | neuron projection organization | EPHB2 ITGA3 ZNF804A EEF2K ZNF365 ACTR2 SIPA1L1 EPHA4 EPHA5 EPHB1 | 2.49e-06 | 127 | 241 | 10 | GO:0106027 |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 3.02e-06 | 54 | 241 | 7 | GO:0048013 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPHB2 ATP7A HLA-H ITGA3 TTC3 ZNF804A PTK2 KIDINS220 WASHC5 WRAP73 EEF2K EPS8L3 GOLGA2 ATG5 CACNA1A TBC1D3 USP17L2 SYNE1 ZNF365 ACTR2 TENM3 SIPA1L1 MARK4 TENM1 LRP6 EPHA3 EPHA4 | 3.38e-06 | 863 | 241 | 27 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | EPHB2 ATP7A ATR SPTAN1 LRRTM1 ATG2A PTK2 PIK3R2 SVIL WRAP73 EEF2K EPS8L3 PLCG2 FERMT2 HSPA2 UNC13B ATG5 TBC1D3 USP17L2 SYNE1 DYRK1A ACTR2 PFN3 PIKFYVE CNOT6L SIPA1L1 MARK4 TENM1 HAS2 MAPK9 UNC13A EPHA3 EPHB1 | 3.47e-06 | 1189 | 241 | 33 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | EPHB2 ATP7A ATR LRRTM1 ATG2A ITGA3 ZNF804A HNRNPA2B1 PTK2 PRDM9 KIDINS220 WASHC5 WRAP73 WDR35 EEF2K EPS8L3 PLCG2 FERMT2 GOLGA2 UNC13B ATG5 SYNE1 COLGALT1 PRDM7 ACTR2 PFN3 CDK5RAP3 CNOT6L TENM3 MARK4 TENM1 LRP6 MAPK9 EPHA3 EPHA4 EPHB1 | 3.86e-06 | 1366 | 241 | 36 | GO:0051130 |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 4.77e-06 | 81 | 241 | 8 | GO:0060997 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 6.25e-06 | 4 | 241 | 3 | GO:0061789 | |
| GeneOntologyBiologicalProcess | dendrite development | EPHB2 ATP7A MPDZ KIDINS220 EEF2K CACNA1A CACNA1F SYNE1 ZNF212 ZNF365 ACTR2 SIPA1L1 EPHA4 EPHA5 EPHB1 | 1.02e-05 | 335 | 241 | 15 | GO:0016358 |
| GeneOntologyBiologicalProcess | organelle assembly | EPHB2 IFT172 LRRTM1 ATG2A NEB WASHC5 CLTC WRAP73 ASPM WDR35 GOLGA2 ATG5 TBC1D3 NRAP KRT19 SYNE1 DNAH2 CDC14B ACTR2 DNAH1 PIKFYVE VIPAS39 CNOT6L WDR11 SIPA1L1 MARK4 TTC21B IFT122 MAPK9 HYDIN RPL11 | 1.03e-05 | 1138 | 241 | 31 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | INTS1 BIRC6 PTK2 SERPINB13 TBC1D3I FERMT2 TBC1D3G TBC1D3K TBC1D3F TBC1D3E MICAL1 TBC1D3 USP17L2 PNLIP TBC1D3H TBC1D3L TBC1D3D APAF1 TBC1D3C TBC1D3B CDK5RAP3 AIFM1 SIPA1L1 EPHA3 EPHA4 EPHA5 | 1.37e-05 | 878 | 241 | 26 | GO:0051336 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | EPHB2 ATR MYO5A SPTAN1 LRRTM1 ATG2A NEB HNRNPA2B1 PTK2 PRDM9 WASHC5 PIK3R2 SVIL CLTC WRAP73 WDR35 FERMT2 ATG5 TBC1D3 SYNE1 DYRK1A PRDM7 SLAMF1 PFN3 PIKFYVE CDK5RAP3 CNOT6L SIPA1L1 MARK4 HASPIN TENM1 MAPK9 EPHA3 EPHA5 | 1.69e-05 | 1342 | 241 | 34 | GO:0033043 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB2 BOC ATP7A HLA-H MPDZ ITGA3 TTC3 ZNF804A PTK2 NEFH KIDINS220 WASHC5 EEF2K GOLGA2 CACNA1A CACNA1F TNC SYNE1 ZNF212 ZSWIM6 GRM7 ZNF365 ACTR2 TENM3 SIPA1L1 B3GNT2 LRP6 MAPK9 UNC13A EPHA3 EPHA4 EPHA5 EPHB1 | 1.74e-05 | 1285 | 241 | 33 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 BOC ATP7A NAGLU HLA-H MPDZ ITGA3 TTC3 ZNF804A PTK2 NEFH KIDINS220 WASHC5 EEF2K GOLGA2 CACNA1A CACNA1F TNC SYNE1 ZNF212 ZSWIM6 GRM7 OGDH ZNF365 ACTR2 TENM3 SIPA1L1 B3GNT2 TENM1 LRP6 MAPK9 UNC13A EPHA3 EPHA4 EPHA5 EPHB1 | 1.74e-05 | 1463 | 241 | 36 | GO:0048666 |
| GeneOntologyBiologicalProcess | synapse organization | EPHB2 MYO5A LRRTM1 ITGA3 ZNF804A PTK2 NEFH EEF2K UNC13B CACNA1A CACNA1S TNC ZNF365 ACTR2 TENM3 SIPA1L1 CNTNAP4 UNC13A EPHA3 EPHA4 EPHA5 EPHB1 | 1.93e-05 | 685 | 241 | 22 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3I FERMT2 TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 USP17L2 PNLIP TBC1D3H TBC1D3L TBC1D3D APAF1 TBC1D3C TBC1D3B AIFM1 SIPA1L1 EPHA4 | 2.53e-05 | 499 | 241 | 18 | GO:0051345 |
| GeneOntologyBiologicalProcess | microtubule-based process | SPEM3 MYO5A IFT172 PTK2 NEFH WASHC5 CLTC WRAP73 ASPM WDR35 HOOK2 GOLGA2 ATG5 CACNA1E RANBP10 DNAH2 DYRK1A SAPCD2 CDC14B ACTR2 KIF7 DNAH1 INTS13 MARK4 TTC21B IFT122 HYDIN EPHA3 | 4.74e-05 | 1058 | 241 | 28 | GO:0007017 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | EPHB2 ATP7A ATR LRRTM1 ATG2A WRAP73 EEF2K EPS8L3 PLCG2 FERMT2 UNC13B ATG5 ACTR2 PFN3 CNOT6L MARK4 TENM1 MAPK9 EPHB1 | 5.83e-05 | 582 | 241 | 19 | GO:0044089 |
| GeneOntologyBiologicalProcess | cell projection assembly | EPHB2 ATP7A IFT172 NEFH WRAP73 WDR35 EPS8L3 ATG5 TBC1D3 USP17L2 SYNE1 DNAH2 CDC14B ACTR2 DNAH1 WDR11 MARK4 TTC21B TENM1 IFT122 HYDIN | 5.86e-05 | 685 | 241 | 21 | GO:0030031 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | EPHB2 ATP7A ITGA3 ZNF804A KIDINS220 WASHC5 WRAP73 EEF2K EPS8L3 GOLGA2 ACTR2 TENM3 MARK4 TENM1 LRP6 EPHA3 EPHA4 | 7.61e-05 | 494 | 241 | 17 | GO:0031346 |
| GeneOntologyBiologicalProcess | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 8.45e-05 | 8 | 241 | 3 | GO:0071947 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPHB2 HLA-H ITGA3 TTC3 ZNF804A PTK2 KIDINS220 WASHC5 EEF2K GOLGA2 CACNA1A SYNE1 ZNF365 ACTR2 TENM3 SIPA1L1 LRP6 EPHA3 EPHA4 | 1.13e-04 | 612 | 241 | 19 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | EPHB2 LRRTM1 ATG2A WRAP73 ATG5 TBC1D3 SYNE1 PIKFYVE CNOT6L SIPA1L1 MARK4 MAPK9 | 1.20e-04 | 280 | 241 | 12 | GO:1902115 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | EPHB2 ATP7A IFT172 WRAP73 WDR35 EPS8L3 ATG5 TBC1D3 USP17L2 SYNE1 DNAH2 CDC14B ACTR2 DNAH1 WDR11 MARK4 TTC21B TENM1 IFT122 HYDIN | 1.26e-04 | 670 | 241 | 20 | GO:0120031 |
| GeneOntologyBiologicalProcess | fasciculation of motor neuron axon | 1.36e-04 | 2 | 241 | 2 | GO:0097156 | |
| GeneOntologyBiologicalProcess | negative regulation of CD40 signaling pathway | 1.36e-04 | 2 | 241 | 2 | GO:2000349 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 1.36e-04 | 2 | 241 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | EPHB2 ATP7A HNRNPA2B1 PTK2 GHR CHTF8 DNAJC10 PLCG2 TBC1D3I FERMT2 TBC1D3G HSPA2 TBC1D3K TBC1D3F PRKD2 TBC1D3E TBC1D3 USP17L2 PNLIP TBC1D3H TBC1D3L TBC1D3D APAF1 TBC1D3C CDC14B TBC1D3B AIFM1 SIPA1L1 TENM1 LRP6 RPL11 EPHA4 EPHA5 | 1.39e-04 | 1430 | 241 | 33 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | EPHB2 ATP7A WRAP73 EPS8L3 ATG5 TBC1D3 USP17L2 SYNE1 ACTR2 MARK4 TENM1 | 1.70e-04 | 248 | 241 | 11 | GO:0120032 |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 1.78e-04 | 10 | 241 | 3 | GO:0099525 | |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 1.82e-04 | 71 | 241 | 6 | GO:0021695 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | ATP7A HNRNPA2B1 PTK2 GHR CHTF8 TBC1D3I FERMT2 TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 USP17L2 PNLIP TBC1D3H TBC1D3L TBC1D3D APAF1 TBC1D3C CDC14B TBC1D3B AIFM1 SIPA1L1 TENM1 EPHA4 EPHA5 | 1.85e-04 | 1028 | 241 | 26 | GO:0043085 |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | EPHB2 ATP7A WRAP73 EPS8L3 ATG5 TBC1D3 USP17L2 SYNE1 ACTR2 MARK4 TENM1 | 1.89e-04 | 251 | 241 | 11 | GO:0060491 |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 1.90e-04 | 25 | 241 | 4 | GO:0048791 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB2 BOC ATP7A TTC3 PTK2 NEFH KIDINS220 EEF2K GOLGA2 CACNA1A CACNA1F SYNE1 ZSWIM6 ZNF365 ACTR2 SIPA1L1 B3GNT2 UNC13A EPHA3 EPHA4 EPHA5 EPHB1 | 1.94e-04 | 802 | 241 | 22 | GO:0048812 |
| GeneOntologyBiologicalProcess | cilium assembly | IFT172 WRAP73 WDR35 ATG5 TBC1D3 SYNE1 DNAH2 CDC14B ACTR2 DNAH1 WDR11 MARK4 TTC21B IFT122 HYDIN | 2.45e-04 | 444 | 241 | 15 | GO:0060271 |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | EPHB2 ATP7A IFT172 PTK2 CACNA1A ZSWIM6 OGDH TTC21B EPHA4 EPHB1 | 2.47e-04 | 217 | 241 | 10 | GO:0021953 |
| GeneOntologyBiologicalProcess | dendritic spine development | 2.58e-04 | 141 | 241 | 8 | GO:0060996 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB2 BOC ATP7A TTC3 PTK2 NEFH KIDINS220 EEF2K GOLGA2 CACNA1A CACNA1F SYNE1 ZSWIM6 ZNF365 ACTR2 SIPA1L1 B3GNT2 UNC13A EPHA3 EPHA4 EPHA5 EPHB1 | 2.59e-04 | 819 | 241 | 22 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB2 BOC ATP7A TTC3 PTK2 NEFH KIDINS220 EEF2K GOLGA2 CACNA1A CACNA1F SYNE1 ZSWIM6 ZNF365 ACTR2 SIPA1L1 B3GNT2 UNC13A EPHA3 EPHA4 EPHA5 EPHB1 | 2.92e-04 | 826 | 241 | 22 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 3.21e-04 | 12 | 241 | 3 | GO:0099011 | |
| GeneOntologyBiologicalProcess | postsynapse organization | EPHB2 LRRTM1 ITGA3 ZNF804A NEFH EEF2K ZNF365 ACTR2 SIPA1L1 EPHA4 EPHA5 EPHB1 | 3.34e-04 | 313 | 241 | 12 | GO:0099173 |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 4.05e-04 | 3 | 241 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | fasciculation of sensory neuron axon | 4.05e-04 | 3 | 241 | 2 | GO:0097155 | |
| GeneOntologyBiologicalProcess | cerebellar molecular layer development | 4.05e-04 | 3 | 241 | 2 | GO:0021679 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB2 MYO5A MPDZ LRRTM1 ITGA3 ZNF804A PTK2 NEFH EEF2K FERMT2 UNC13B CACNA1A CACNA1S TNC ZNF365 ACTR2 TENM3 SIPA1L1 CNTNAP4 UNC13A EPHA3 EPHA4 EPHA5 EPHB1 | 4.79e-04 | 974 | 241 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | cilium organization | IFT172 WRAP73 WDR35 ATG5 TBC1D3 SYNE1 DNAH2 CDC14B ACTR2 DNAH1 WDR11 MARK4 TTC21B IFT122 HYDIN | 5.10e-04 | 476 | 241 | 15 | GO:0044782 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB2 BOC ATP7A TTC3 PTK2 NEFH KIDINS220 EEF2K GOLGA2 CACNA1A CACNA1F SYNE1 ZNF365 ACTR2 SIPA1L1 B3GNT2 EPHA3 EPHA4 EPHA5 EPHB1 | 5.25e-04 | 748 | 241 | 20 | GO:0048667 |
| GeneOntologyBiologicalProcess | intermembrane lipid transfer | 6.40e-04 | 34 | 241 | 4 | GO:0120009 | |
| GeneOntologyBiologicalProcess | secretory granule localization | 6.40e-04 | 34 | 241 | 4 | GO:0032252 | |
| GeneOntologyBiologicalProcess | intraciliary retrograde transport | 6.46e-04 | 15 | 241 | 3 | GO:0035721 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 6.46e-04 | 15 | 241 | 3 | GO:1990504 | |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 6.76e-04 | 60 | 241 | 5 | GO:0021587 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | EPHB2 ITGA3 ZNF804A KIDINS220 WASHC5 EEF2K ACTR2 TENM3 LRP6 EPHA3 | 7.27e-04 | 249 | 241 | 10 | GO:0010976 |
| GeneOntologyBiologicalProcess | microtubule-based movement | SPEM3 MYO5A IFT172 NEFH WDR35 ATG5 CACNA1E DNAH2 ACTR2 KIF7 DNAH1 INTS13 TTC21B IFT122 HYDIN | 7.30e-04 | 493 | 241 | 15 | GO:0007018 |
| GeneOntologyBiologicalProcess | regulation of protein localization to plasma membrane | 7.77e-04 | 128 | 241 | 7 | GO:1903076 | |
| GeneOntologyBiologicalProcess | hindbrain development | 7.88e-04 | 208 | 241 | 9 | GO:0030902 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway, planar cell polarity pathway | 8.03e-04 | 4 | 241 | 2 | GO:0141113 | |
| GeneOntologyBiologicalProcess | positive regulation of reciprocal meiotic recombination | 8.03e-04 | 4 | 241 | 2 | GO:0010845 | |
| GeneOntologyBiologicalProcess | regulation of reciprocal meiotic recombination | 8.03e-04 | 4 | 241 | 2 | GO:0010520 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | EPHB2 MYO5A LRRTM1 PTK2 NEFH UNC13B ATG5 CACNA1A CACNA1E SYNE1 GRM7 SIPA1L1 CNTNAP4 UNC13C MAPK9 UNC13A EPHA4 EPHB1 | 8.37e-04 | 663 | 241 | 18 | GO:0050804 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | IFT172 PTK2 NEFH WASHC5 CLTC WRAP73 ASPM HOOK2 GOLGA2 RANBP10 DNAH2 DYRK1A SAPCD2 CDC14B DNAH1 INTS13 MARK4 HYDIN EPHA3 | 8.45e-04 | 720 | 241 | 19 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | EPHB2 MYO5A LRRTM1 PTK2 NEFH UNC13B ATG5 CACNA1A CACNA1E SYNE1 GRM7 SIPA1L1 CNTNAP4 UNC13C MAPK9 UNC13A EPHA4 EPHB1 | 8.51e-04 | 664 | 241 | 18 | GO:0099177 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | ATP7A MYO5A IFT172 SPTAN1 NEB NEFH WASHC5 PIK3R2 SVIL EEF2K HOOK2 CORO7 FERMT2 GOLGA2 MICAL1 NRAP KRT19 DYRK1A COLGALT1 ACTR2 PFN3 VIPAS39 TENM1 | 8.81e-04 | 957 | 241 | 23 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of dendritic spine morphogenesis | 9.09e-04 | 64 | 241 | 5 | GO:0061001 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 9.09e-04 | 64 | 241 | 5 | GO:0021575 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell periphery | 9.28e-04 | 171 | 241 | 8 | GO:1904375 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 9.32e-04 | 132 | 241 | 7 | GO:0035249 | |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 9.32e-04 | 132 | 241 | 7 | GO:0006022 | |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 9.49e-04 | 17 | 241 | 3 | GO:0016081 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle assembly | 9.74e-04 | 97 | 241 | 6 | GO:1902117 | |
| GeneOntologyBiologicalProcess | forebrain generation of neurons | 9.75e-04 | 65 | 241 | 5 | GO:0021872 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | ATR SPTAN1 ATG2A SVIL CLTC EEF2K MMP7 HSPA2 GOLGA2 ATG5 MICAL1 APAF1 GSPT1 VIPAS39 CDK5RAP3 AIFM1 EPHA4 | 9.91e-04 | 617 | 241 | 17 | GO:0022411 |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 1.08e-03 | 99 | 241 | 6 | GO:0021954 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer development | 1.08e-03 | 39 | 241 | 4 | GO:0021680 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 BOC CNTNAP3B ATP7A MYO5A CNTNAP3 MPDZ ZNF804A HNRNPA2B1 PTK2 GHR NEFH WASHC5 EEF2K GOLGA2 CACNA1A CACNA1E CACNA1F CACNA1S SYNE1 DYRK1A GRM7 SIPA1L1 MARK4 CNTNAP4 LRP6 WDFY3 MAPK9 EPHA3 EPHA4 EPHA5 EPHB1 | 1.48e-05 | 1228 | 242 | 32 | GO:0036477 |
| GeneOntologyCellularComponent | perikaryon | CNTNAP3B ATP7A CNTNAP3 HNRNPA2B1 NEFH CACNA1A CACNA1E CACNA1F WDFY3 MAPK9 EPHA4 | 6.13e-05 | 223 | 242 | 11 | GO:0043204 |
| GeneOntologyCellularComponent | intraciliary transport particle A | 8.22e-05 | 8 | 242 | 3 | GO:0030991 | |
| GeneOntologyCellularComponent | presynaptic membrane | EPHB2 ITGA3 CLTC UNC13B CACNA1A CACNA1E GRM7 TENM3 CNTNAP4 UNC13C UNC13A EPHA4 | 9.93e-05 | 277 | 242 | 12 | GO:0042734 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.86e-04 | 46 | 242 | 5 | GO:0005891 | |
| GeneOntologyCellularComponent | early endosome membrane | ATP7A HLA-H MR1 WASHC5 TBC1D3 RUFY1 PIKFYVE LRP6 EPHA4 EPHB1 | 1.90e-04 | 212 | 242 | 10 | GO:0031901 |
| GeneOntologyCellularComponent | calcium channel complex | 2.02e-04 | 73 | 242 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | ciliary tip | 2.28e-04 | 48 | 242 | 5 | GO:0097542 | |
| GeneOntologyCellularComponent | intraciliary transport particle | 2.88e-04 | 28 | 242 | 4 | GO:0030990 | |
| GeneOntologyCellularComponent | axon | EPHB2 BOC CNTNAP3B ATP7A MYO5A SPTAN1 CNTNAP3 LRRTM1 ITGA3 ZNF804A NEFH UNC13B ATG5 MICAL1 DYRK1A GRM7 TENM3 UNC13C WDFY3 UNC13A EPHA4 EPHA5 EPHB1 | 2.91e-04 | 891 | 242 | 23 | GO:0030424 |
| GeneOntologyCellularComponent | neuronal cell body | EPHB2 BOC CNTNAP3B ATP7A MYO5A CNTNAP3 ZNF804A HNRNPA2B1 GHR NEFH WASHC5 GOLGA2 CACNA1A CACNA1E CACNA1F GRM7 SIPA1L1 LRP6 WDFY3 MAPK9 EPHA4 EPHA5 | 2.99e-04 | 835 | 242 | 22 | GO:0043025 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L21 COPZ2 USP17L20 HLA-H MR1 TMTC2 USP17L19 ATG2A RYR3 USP17L18 USP17L17 USP17L3 TRPM8 USP17L13 USP17L4 USP17L2 USP17L12 ESYT1 USP17L11 SYNE1 USP17L5 USP17L10 CDK5RAP3 USP17L6P PNPLA8 HAS2 USP17L22 USP17L15 USP17L8 | 3.47e-04 | 1327 | 242 | 30 | GO:0042175 |
| GeneOntologyCellularComponent | phagophore | 3.97e-04 | 3 | 242 | 2 | GO:0061908 | |
| GeneOntologyCellularComponent | ciliary basal body | 4.65e-04 | 195 | 242 | 9 | GO:0036064 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 USP17L21 COPZ2 USP17L20 HLA-H MR1 TMTC2 USP17L19 ATG2A RYR3 USP17L18 USP17L17 USP17L3 TRPM8 USP17L13 USP17L4 USP17L2 USP17L12 ESYT1 USP17L11 USP17L5 USP17L10 CDK5RAP3 USP17L6P PNPLA8 HAS2 USP17L22 USP17L15 USP17L8 | 4.97e-04 | 1293 | 242 | 29 | GO:0005789 |
| GeneOntologyCellularComponent | cell body | EPHB2 BOC CNTNAP3B ATP7A MYO5A CNTNAP3 ZNF804A HNRNPA2B1 GHR NEFH WASHC5 GOLGA2 CACNA1A PITPNM2 CACNA1E CACNA1F GRM7 SIPA1L1 LRP6 WDFY3 MAPK9 EPHA4 EPHA5 | 5.21e-04 | 929 | 242 | 23 | GO:0044297 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 USP17L21 COPZ2 USP17L20 HLA-H MR1 TMTC2 USP17L19 ATG2A RYR3 USP17L18 USP17L17 USP17L3 TRPM8 USP17L13 USP17L4 USP17L2 USP17L12 ESYT1 USP17L11 USP17L5 USP17L10 CDK5RAP3 USP17L6P PNPLA8 HAS2 USP17L22 USP17L15 USP17L8 | 5.36e-04 | 1299 | 242 | 29 | GO:0098827 |
| GeneOntologyCellularComponent | I band | 7.21e-04 | 166 | 242 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | postsynapse | EPHB2 ATP7A ATR MYO5A SPTAN1 MPDZ LRRTM1 ITGA3 ZNF804A HNRNPA2B1 PTK2 NEFH CLTC EEF2K CACNA1A CACNA1E CACNA1S SYNE1 GRM7 TAMALIN ACTR2 SIPA1L1 EIF3A EPHA4 | 7.83e-04 | 1018 | 242 | 24 | GO:0098794 |
| GeneOntologyCellularComponent | cytoplasmic region | IFT172 HNRNPA2B1 WDR35 UNC13B ATG5 DNAH2 SAPCD2 DNAH1 WDR11 UNC13C HYDIN UNC13A | 1.05e-03 | 360 | 242 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | presynaptic active zone | 1.30e-03 | 141 | 242 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | myofibril | 1.36e-03 | 273 | 242 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | glutamatergic synapse | EPHB2 MYO5A SPTAN1 MPDZ LRRTM1 ITGA3 HNRNPA2B1 PTK2 CLTC EEF2K UNC13B ATG5 CACNA1A GRM7 TAMALIN TENM3 SIPA1L1 UNC13A EPHA4 EPHB1 | 1.38e-03 | 817 | 242 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | cell cortex region | 1.80e-03 | 45 | 242 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | Atg12-Atg5-Atg16 complex | 1.94e-03 | 6 | 242 | 2 | GO:0034274 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.12e-03 | 290 | 242 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.29e-03 | 23 | 242 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 2.40e-03 | 157 | 242 | 7 | GO:0045335 | |
| GeneOntologyCellularComponent | dendrite | EPHB2 ATP7A MYO5A MPDZ ZNF804A PTK2 NEFH EEF2K CACNA1A CACNA1S SYNE1 DYRK1A GRM7 SIPA1L1 MARK4 CNTNAP4 EPHA3 EPHA4 EPHA5 EPHB1 | 2.44e-03 | 858 | 242 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB2 ATP7A MYO5A MPDZ ZNF804A PTK2 NEFH EEF2K CACNA1A CACNA1S SYNE1 DYRK1A GRM7 SIPA1L1 MARK4 CNTNAP4 EPHA3 EPHA4 EPHA5 EPHB1 | 2.50e-03 | 860 | 242 | 20 | GO:0097447 |
| GeneOntologyCellularComponent | sarcomere | 2.56e-03 | 249 | 242 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | microtubule minus-end | 2.70e-03 | 7 | 242 | 2 | GO:0036449 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 2.24e-25 | 16 | 237 | 14 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 2.24e-25 | 16 | 237 | 14 | IPR006861 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 4.91e-19 | 70 | 237 | 18 | PS00972 |
| Domain | UCH | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 6.50e-19 | 71 | 237 | 18 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 6.50e-19 | 71 | 237 | 18 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 8.57e-19 | 72 | 237 | 18 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 8.57e-19 | 72 | 237 | 18 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 8.57e-19 | 72 | 237 | 18 | IPR001394 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP32 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 4.66e-18 | 66 | 237 | 17 | IPR018200 |
| Domain | TBC | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 4.77e-10 | 49 | 237 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.08e-09 | 53 | 237 | 10 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.59e-09 | 55 | 237 | 10 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.59e-09 | 55 | 237 | 10 | PS50086 |
| Domain | RECEPTOR_TYR_KIN_V_2 | 5.75e-07 | 14 | 237 | 5 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 5.75e-07 | 14 | 237 | 5 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 5.75e-07 | 14 | 237 | 5 | IPR001426 | |
| Domain | EphA2_TM | 5.75e-07 | 14 | 237 | 5 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 5.75e-07 | 14 | 237 | 5 | IPR001090 | |
| Domain | Eph_TM | 5.75e-07 | 14 | 237 | 5 | IPR027936 | |
| Domain | EPH_lbd | 5.75e-07 | 14 | 237 | 5 | SM00615 | |
| Domain | Ephrin_lbd | 5.75e-07 | 14 | 237 | 5 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 5.75e-07 | 14 | 237 | 5 | IPR016257 | |
| Domain | EPH_LBD | 5.75e-07 | 14 | 237 | 5 | PS51550 | |
| Domain | Ca_chan_IQ | 8.59e-07 | 7 | 237 | 4 | SM01062 | |
| Domain | Ca_chan_IQ | 8.59e-07 | 7 | 237 | 4 | PF08763 | |
| Domain | VDCC_a1su_IQ | 8.59e-07 | 7 | 237 | 4 | IPR014873 | |
| Domain | GPHH | 8.59e-07 | 7 | 237 | 4 | PF16905 | |
| Domain | GPHH_dom | 8.59e-07 | 7 | 237 | 4 | IPR031649 | |
| Domain | Unc-13 | 2.02e-06 | 3 | 237 | 3 | IPR027080 | |
| Domain | VDCCAlpha1 | 5.00e-06 | 10 | 237 | 4 | IPR002077 | |
| Domain | TPR-like_helical_dom | ATR IFT172 SRP68 TMTC2 TTC3 CLTC WDR35 EEF2K FEM1A ZC3H7A TMTC1 TTC21B IFT122 | 9.23e-06 | 233 | 237 | 13 | IPR011990 |
| Domain | Ephrin_rec_like | 1.36e-05 | 25 | 237 | 5 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.36e-05 | 25 | 237 | 5 | IPR011641 | |
| Domain | Munc13_dom-2 | 1.98e-05 | 5 | 237 | 3 | IPR014772 | |
| Domain | MHD2 | 1.98e-05 | 5 | 237 | 3 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 1.98e-05 | 5 | 237 | 3 | IPR019558 | |
| Domain | Membr_traf_MHD | 1.98e-05 | 5 | 237 | 3 | PF10540 | |
| Domain | DUF1041 | 1.98e-05 | 5 | 237 | 3 | SM01145 | |
| Domain | Galactose-bd-like | 2.60e-05 | 94 | 237 | 8 | IPR008979 | |
| Domain | - | 3.88e-05 | 73 | 237 | 7 | 2.60.120.260 | |
| Domain | fn3 | 4.30e-05 | 162 | 237 | 10 | PF00041 | |
| Domain | FIBRINOGEN_C_1 | 4.80e-05 | 32 | 237 | 5 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 4.80e-05 | 32 | 237 | 5 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 4.80e-05 | 32 | 237 | 5 | PS51406 | |
| Domain | Munc13_1 | 6.80e-05 | 7 | 237 | 3 | IPR014770 | |
| Domain | MHD1 | 6.80e-05 | 7 | 237 | 3 | PS51258 | |
| Domain | DUF1041 | 6.80e-05 | 7 | 237 | 3 | PF06292 | |
| Domain | CAPS_dom | 6.80e-05 | 7 | 237 | 3 | IPR010439 | |
| Domain | FN3 | 1.30e-04 | 185 | 237 | 10 | SM00060 | |
| Domain | 2-oxogl_dehyd_N | 1.60e-04 | 2 | 237 | 2 | IPR032106 | |
| Domain | ASH | 1.60e-04 | 2 | 237 | 2 | IPR031549 | |
| Domain | 2-oxogl_dehyd_N | 1.60e-04 | 2 | 237 | 2 | PF16078 | |
| Domain | ASH | 1.60e-04 | 2 | 237 | 2 | PF15780 | |
| Domain | FN3 | 2.36e-04 | 199 | 237 | 10 | PS50853 | |
| Domain | - | 3.24e-04 | 207 | 237 | 10 | 1.25.40.10 | |
| Domain | FN3_dom | 3.49e-04 | 209 | 237 | 10 | IPR003961 | |
| Domain | FBG | 4.68e-04 | 29 | 237 | 4 | SM00186 | |
| Domain | 2oxoglutarate_DH_E1 | 4.77e-04 | 3 | 237 | 2 | IPR011603 | |
| Domain | KGD_C | 4.77e-04 | 3 | 237 | 2 | IPR031717 | |
| Domain | OxoGdeHyase_C | 4.77e-04 | 3 | 237 | 2 | PF16870 | |
| Domain | - | 5.34e-04 | 30 | 237 | 4 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 5.34e-04 | 30 | 237 | 4 | IPR014716 | |
| Domain | Glycoside_hydrolase_SF | 5.51e-04 | 53 | 237 | 5 | IPR017853 | |
| Domain | EGF_2 | EPHB2 CNTNAP3B CNTNAP3 TNC TENM3 TENM1 CNTNAP4 LRP6 EPHA3 EPHA5 EPHB1 | 5.96e-04 | 265 | 237 | 11 | PS01186 |
| Domain | Ion_trans_dom | 6.31e-04 | 114 | 237 | 7 | IPR005821 | |
| Domain | Ion_trans | 6.31e-04 | 114 | 237 | 7 | PF00520 | |
| Domain | WD40 | IFT172 HIRA WRAP73 WDR35 MIOS CORO7 APAF1 TEP1 WDR11 IFT122 WDFY3 | 6.54e-04 | 268 | 237 | 11 | SM00320 |
| Domain | WD40_repeat | IFT172 HIRA WRAP73 WDR35 MIOS CORO7 APAF1 TEP1 WDR11 IFT122 WDFY3 | 7.39e-04 | 272 | 237 | 11 | IPR001680 |
| Domain | WD_REPEATS_1 | IFT172 HIRA WRAP73 WDR35 MIOS CORO7 APAF1 TEP1 WDR11 IFT122 WDFY3 | 8.84e-04 | 278 | 237 | 11 | PS00678 |
| Domain | Tyr_kinase_cat_dom | 8.92e-04 | 88 | 237 | 6 | IPR020635 | |
| Domain | TyrKc | 8.92e-04 | 88 | 237 | 6 | SM00219 | |
| Domain | WD_REPEATS_2 | IFT172 HIRA WRAP73 WDR35 MIOS CORO7 APAF1 TEP1 WDR11 IFT122 WDFY3 | 9.10e-04 | 279 | 237 | 11 | PS50082 |
| Domain | WD_REPEATS_REGION | IFT172 HIRA WRAP73 WDR35 MIOS CORO7 APAF1 TEP1 WDR11 IFT122 WDFY3 | 9.10e-04 | 279 | 237 | 11 | PS50294 |
| Domain | Nebulin | 9.46e-04 | 4 | 237 | 2 | PF00880 | |
| Domain | Tox-GHH_dom | 9.46e-04 | 4 | 237 | 2 | IPR028916 | |
| Domain | DUF1736 | 9.46e-04 | 4 | 237 | 2 | IPR013618 | |
| Domain | NEBULIN | 9.46e-04 | 4 | 237 | 2 | PS51216 | |
| Domain | VDCC_L_a1su | 9.46e-04 | 4 | 237 | 2 | IPR005446 | |
| Domain | Tox-GHH | 9.46e-04 | 4 | 237 | 2 | PF15636 | |
| Domain | NEBU | 9.46e-04 | 4 | 237 | 2 | SM00227 | |
| Domain | Nebulin | 9.46e-04 | 4 | 237 | 2 | IPR013998 | |
| Domain | Ten_N | 9.46e-04 | 4 | 237 | 2 | IPR009471 | |
| Domain | Ten_N | 9.46e-04 | 4 | 237 | 2 | PF06484 | |
| Domain | Nebulin_repeat | 9.46e-04 | 4 | 237 | 2 | IPR000900 | |
| Domain | TENEURIN_N | 9.46e-04 | 4 | 237 | 2 | PS51361 | |
| Domain | DUF1736 | 9.46e-04 | 4 | 237 | 2 | PF08409 | |
| Domain | - | 9.72e-04 | 35 | 237 | 4 | 3.20.20.80 | |
| Domain | - | IFT172 BIRC6 HIRA WRAP73 WDR35 MIOS CORO7 APAF1 TEP1 WDR11 IFT122 WDFY3 | 1.17e-03 | 333 | 237 | 12 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | IFT172 BIRC6 HIRA WRAP73 WDR35 MIOS CORO7 APAF1 TEP1 WDR11 IFT122 WDFY3 | 1.23e-03 | 335 | 237 | 12 | IPR015943 |
| Domain | TPR_REGION | 1.24e-03 | 165 | 237 | 8 | PS50293 | |
| Domain | TPR | 1.24e-03 | 165 | 237 | 8 | PS50005 | |
| Domain | Pkinase_Tyr | 1.31e-03 | 129 | 237 | 7 | PF07714 | |
| Domain | Glyco_hydro_catalytic_dom | 1.33e-03 | 38 | 237 | 4 | IPR013781 | |
| Domain | PROTEIN_KINASE_TYR | 1.48e-03 | 97 | 237 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.48e-03 | 97 | 237 | 6 | IPR008266 | |
| Domain | WD40_repeat_dom | IFT172 HIRA WDR35 MIOS CORO7 APAF1 TEP1 TENM3 WDR11 IFT122 WDFY3 | 1.50e-03 | 297 | 237 | 11 | IPR017986 |
| Domain | YD | 1.56e-03 | 5 | 237 | 2 | IPR006530 | |
| Domain | WD40 | IFT172 HIRA WRAP73 WDR35 CORO7 APAF1 TEP1 WDR11 IFT122 WDFY3 | 1.80e-03 | 259 | 237 | 10 | PF00400 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.93e-03 | 138 | 237 | 7 | IPR001245 | |
| Domain | MHC_I | 2.27e-03 | 21 | 237 | 3 | PF00129 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.25e-23 | 45 | 185 | 18 | MM15671 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L20 SPTAN1 USP17L19 SHC3 PTK2 USP17L18 USP17L17 PIK3R2 FGB USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 CDC14B USP17L6P USP17L22 USP17L15 USP17L8 | 4.20e-12 | 318 | 185 | 24 | MM15278 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.31e-11 | 191 | 185 | 18 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L20 TNIP3 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P TNFAIP3 USP17L22 USP17L15 USP17L8 | 2.37e-10 | 262 | 185 | 20 | MM15286 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 USP17L8 | 5.06e-09 | 221 | 185 | 17 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L20 TNIP3 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 TNFAIP3 USP17L22 USP17L15 USP17L8 | 1.43e-08 | 299 | 185 | 19 | M27574 |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3I TBC1D3G TBC1D3K TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B | 5.96e-06 | 99 | 185 | 9 | M46448 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 8.82e-06 | 11 | 185 | 4 | M47958 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.02e-05 | 23 | 185 | 5 | M47666 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 2.75e-05 | 92 | 185 | 8 | M27201 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 5.19e-05 | 51 | 185 | 6 | M27311 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 2.93e-04 | 25 | 185 | 4 | M47948 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.26e-36 | 21 | 245 | 18 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.26e-36 | 21 | 245 | 18 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.26e-36 | 21 | 245 | 18 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.26e-36 | 21 | 245 | 18 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.26e-36 | 21 | 245 | 18 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.26e-36 | 21 | 245 | 18 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.90e-36 | 22 | 245 | 18 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-34 | 24 | 245 | 18 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.45e-34 | 25 | 245 | 18 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.44e-33 | 26 | 245 | 18 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.74e-33 | 33 | 245 | 19 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 20368735 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.07e-32 | 34 | 245 | 19 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.32e-32 | 35 | 245 | 19 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.32e-32 | 35 | 245 | 19 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.12e-32 | 29 | 245 | 18 | 32527007 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.88e-32 | 36 | 245 | 19 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.98e-32 | 37 | 245 | 19 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.43e-26 | 50 | 245 | 18 | 31806660 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.69e-24 | 11 | 245 | 11 | 16863688 |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | USP17L7 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 EPHA3 | 1.57e-14 | 14 | 245 | 8 | 11793228 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 9.31e-14 | 10 | 245 | 7 | 24207026 | |
| Pubmed | 6.07e-13 | 12 | 245 | 7 | 24695638 | ||
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 3.70e-11 | 19 | 245 | 7 | 28067227 | |
| Pubmed | USP17L7 USP17L21 MAGEB1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 MRC1 NDUFB11 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 STK31 AIFM1 USP17L6P USP17L22 USP17L15 USP17L8 | 6.00e-10 | 674 | 245 | 23 | 37196079 | |
| Pubmed | 2.05e-09 | 9 | 245 | 5 | 11403717 | ||
| Pubmed | USP17L7 FREM1 USP32 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 | 6.19e-09 | 81 | 245 | 9 | 12838346 | |
| Pubmed | 7.43e-09 | 11 | 245 | 5 | 22171039 | ||
| Pubmed | 1.19e-08 | 5 | 245 | 4 | 12604796 | ||
| Pubmed | ATP7A MYO5A SPTAN1 MRPS35 MPDZ TTC3 HNRNPA2B1 KIDINS220 STXBP3 DNAJC10 PIK3R2 CLTC WRAP73 ASPM EEF2K FERMT2 HSPA2 NDUFB11 ESYT1 SYNE1 APAF1 COLGALT1 PRPF8 OGDH KIF7 ZC3H7A CDK5RAP3 WDR11 AIFM1 C1orf52 PNPLA8 IFT122 | 2.18e-08 | 1487 | 245 | 32 | 33957083 | |
| Pubmed | MYO5A SPTAN1 SRP68 LRRTM1 HNRNPA2B1 NEFH KIDINS220 WASHC5 SVIL CLTC MIOS CORO7 FERMT2 HSPA2 GPD2 CACNA1A PITPNM2 NDUFB11 MICAL1 SRSF5 KRT19 TNC SYNE1 DYRK1A OGDH ACTR2 SIPA1L1 OGDHL EIF3A UNC13A RPL11 | 3.19e-08 | 1431 | 245 | 31 | 37142655 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | USP17L7 INTS1 NAGLU SRP68 BIRC6 HNRNPA2B1 FOCAD MCM3AP CLTC USP17L3 CACNA1F USP17L12 KRT19 BAZ2B TAS1R3 DNAH2 PRPF8 AIFM1 EIF3A MAPK9 RPL11 | 7.42e-08 | 736 | 245 | 21 | 29676528 |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 9.62e-08 | 17 | 245 | 5 | 12217323 | |
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 1.79e-07 | 19 | 245 | 5 | 12684176 | |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 2.37e-07 | 20 | 245 | 5 | 11256076 | |
| Pubmed | 2.37e-07 | 20 | 245 | 5 | 10207129 | ||
| Pubmed | 2.37e-07 | 20 | 245 | 5 | 9530499 | ||
| Pubmed | 2.37e-07 | 20 | 245 | 5 | 9576626 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 2.78e-07 | 91 | 245 | 8 | 28558017 | |
| Pubmed | 2.95e-07 | 9 | 245 | 4 | 16382099 | ||
| Pubmed | 2.95e-07 | 9 | 245 | 4 | 18713744 | ||
| Pubmed | 2.95e-07 | 9 | 245 | 4 | 33253166 | ||
| Pubmed | 3.09e-07 | 21 | 245 | 5 | 9267020 | ||
| Pubmed | 3.09e-07 | 21 | 245 | 5 | 11128993 | ||
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 3.09e-07 | 21 | 245 | 5 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 3.09e-07 | 21 | 245 | 5 | 20112066 | |
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 3.09e-07 | 21 | 245 | 5 | 10730216 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | INTS1 NAGLU ATG2A ITGA3 TTC3 BIRC6 HIRA FOCAD MCM3AP FEM1A UNC13B PITPNM2 PRKD2 RANBP10 ESYT1 DYRK1A TEP1 CDC14B NBPF1 PIKFYVE MTMR14 MARK4 OGDHL TNFAIP3 WDFY3 | 3.42e-07 | 1105 | 245 | 25 | 35748872 |
| Pubmed | Identification of ocular regulatory functions of core histone variant H3.2. | 3.45e-07 | 3 | 245 | 3 | 36529279 | |
| Pubmed | 3.45e-07 | 3 | 245 | 3 | 33105896 | ||
| Pubmed | 3.45e-07 | 3 | 245 | 3 | 23658173 | ||
| Pubmed | 3.45e-07 | 3 | 245 | 3 | 22966208 | ||
| Pubmed | 3.45e-07 | 3 | 245 | 3 | 15988013 | ||
| Pubmed | MYO5A SPTAN1 MPDZ LRRTM1 TTC3 PTK2 HIRA NEFH SVIL CLTC MIOS GOLGA2 CACNA1A CACNA1E RANBP10 SYNE1 DYRK1A JAKMIP3 KIF7 SIPA1L1 WDFY3 UNC13A EPHA4 | 4.10e-07 | 963 | 245 | 23 | 28671696 | |
| Pubmed | MYO5A DIS3L IFT172 SPTAN1 MRPS35 TTC3 ZKSCAN5 PTK2 RYR3 FOCAD USP32 CLTC HSPA2 UNC13B ATG5 PRKD2 PTGES2 SYNE1 DYRK1A JAKMIP3 PRPF8 ZNF365 ZNF18 SIPA1L1 IFT122 WDFY3 MORC3 | 4.80e-07 | 1285 | 245 | 27 | 35914814 | |
| Pubmed | 4.88e-07 | 10 | 245 | 4 | 25923646 | ||
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 5.05e-07 | 23 | 245 | 5 | 19542359 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 6.34e-07 | 24 | 245 | 5 | 16446123 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | GBE1 ITGA3 PTK2 WASHC5 PIK3R2 GPD2 PTGES2 CDK5RAP3 MTMR14 HERC4 | 7.80e-07 | 183 | 245 | 10 | 31932471 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DIS3L ATG2A STXBP3 WASHC5 SVIL WRAP73 CZIB TAF2 FERMT2 HSPA2 KRT19 ESYT1 DYRK1A ATE1 RUFY1 KIF7 ZC3H7A MTMR14 WDR11 SIPA1L1 MORC3 | 8.26e-07 | 853 | 245 | 21 | 28718761 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 9.52e-07 | 74 | 245 | 7 | 16625196 | |
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 1.14e-06 | 12 | 245 | 4 | 21465626 | |
| Pubmed | 1.36e-06 | 78 | 245 | 7 | 17192257 | ||
| Pubmed | COPZ2 MYO5A SPTAN1 MRPS35 NEB TTC3 HNRNPA2B1 PHEX DNAJC10 FAM186A CLTC ASPM HSPA2 CACNA1E KRT19 SYNE1 DNAH2 PRPF8 STK31 OGDH ACTR2 GSPT1 ZC3H7A TENM1 OGDHL IFT122 EIF3A EPHA4 | 1.37e-06 | 1442 | 245 | 28 | 35575683 | |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 1.37e-06 | 4 | 245 | 3 | 22984479 | |
| Pubmed | cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases. | 1.37e-06 | 4 | 245 | 3 | 7898931 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.37e-06 | 4 | 245 | 3 | 12359748 | |
| Pubmed | 1.37e-06 | 4 | 245 | 3 | 8406013 | ||
| Pubmed | 1.59e-06 | 51 | 245 | 6 | 19769959 | ||
| Pubmed | SPTAN1 NEB PTK2 PIK3R2 MCM3AP CLTC GOLGA2 TBC1D3F PNLIP KRT19 SYNE1 ZC3H7A EIF3A TNFAIP3 MAPK9 | 2.21e-06 | 486 | 245 | 15 | 20936779 | |
| Pubmed | 2.28e-06 | 14 | 245 | 4 | 26941654 | ||
| Pubmed | DIS3L BIRC6 ZKSCAN5 WDR35 SEC14L1 RANBP10 BAZ2B ZFP30 PIKFYVE WDR11 ZNF665 TTC21B CNTNAP4 EIF3A MORC3 | 2.63e-06 | 493 | 245 | 15 | 15368895 | |
| Pubmed | 3.09e-06 | 15 | 245 | 4 | 20188150 | ||
| Pubmed | 3.09e-06 | 15 | 245 | 4 | 24453333 | ||
| Pubmed | 3.09e-06 | 15 | 245 | 4 | 36028553 | ||
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 3.36e-06 | 33 | 245 | 5 | 26830346 | |
| Pubmed | 3.42e-06 | 5 | 245 | 3 | 7681531 | ||
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 3.42e-06 | 5 | 245 | 3 | 34706221 | |
| Pubmed | 3.42e-06 | 5 | 245 | 3 | 8471161 | ||
| Pubmed | alpha2-Chimaerin is an essential EphA4 effector in the assembly of neuronal locomotor circuits. | 3.42e-06 | 5 | 245 | 3 | 17785183 | |
| Pubmed | Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. | 3.42e-06 | 5 | 245 | 3 | 21559471 | |
| Pubmed | Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases. | 3.42e-06 | 5 | 245 | 3 | 8552593 | |
| Pubmed | Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis. | 3.42e-06 | 5 | 245 | 3 | 26575293 | |
| Pubmed | ATP7A ATG2A KIDINS220 WASHC5 PIK3R2 USP32 MIOS GOLGA2 GPD2 ESYT1 PIKFYVE VIPAS39 CDK5RAP3 TYW1B TENM1 | 3.44e-06 | 504 | 245 | 15 | 34432599 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO5A SPTAN1 SRP68 BIRC6 HNRNPA2B1 PTK2 HIRA WASHC5 MCM3AP CLTC ASPM PLCG2 TAF2 CORO7 FERMT2 ATG5 ESYT1 COLGALT1 PRPF8 GSPT1 ZC3H7A WDR11 AIFM1 EIF3A WDFY3 RPL11 | 4.03e-06 | 1353 | 245 | 26 | 29467282 |
| Pubmed | 4.09e-06 | 16 | 245 | 4 | 8755474 | ||
| Pubmed | 5.05e-06 | 177 | 245 | 9 | 26485645 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | DIS3L SRP68 ATG2A WWC2 STXBP3 WASHC5 MCM3AP WRAP73 EEF2K HOOK2 FERMT2 GOLGA2 ATG5 PITPNM2 PRKD2 SRSF5 DYRK1A SAPCD2 ACTR2 GSPT1 ZC3H7A MTMR14 | 5.09e-06 | 1038 | 245 | 22 | 26673895 |
| Pubmed | Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. | 5.32e-06 | 17 | 245 | 4 | 12971893 | |
| Pubmed | MYO5A SPTAN1 NAGLU BIRC6 WWC2 PTPRB STXBP3 WASHC5 SVIL CLTC MIOS HSPA2 GPD2 COLGALT1 CDC14B KIF7 VIPAS39 MTMR14 WDR11 AIFM1 LRP6 MAPK9 | 6.01e-06 | 1049 | 245 | 22 | 27880917 | |
| Interaction | OAS1 interactions | 1.14e-06 | 17 | 235 | 5 | int:OAS1 | |
| Interaction | EFNA1 interactions | 3.32e-06 | 103 | 235 | 9 | int:EFNA1 | |
| Interaction | EFNA4 interactions | ATR INTS1 ITGA3 LCN1P1 HNRNPA2B1 KIDINS220 WASHC5 COLGALT1 CDK5RAP3 RPL11 EPHA3 EPHA4 EPHA5 | 4.95e-06 | 239 | 235 | 13 | int:EFNA4 |
| Interaction | EPHA3 interactions | 6.16e-06 | 111 | 235 | 9 | int:EPHA3 | |
| Cytoband | 4p16.1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 9.56e-18 | 79 | 245 | 14 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.09e-11 | 222 | 245 | 14 | chr4p16 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 5.76e-10 | 149 | 245 | 11 | chr17q12 |
| Cytoband | 17q12 | 1.98e-04 | 99 | 245 | 5 | 17q12 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 7.65e-08 | 14 | 153 | 5 | 1095 | |
| GeneFamily | Fibronectin type III domain containing | 1.08e-06 | 160 | 153 | 10 | 555 | |
| GeneFamily | UNC13 homologs | 2.36e-06 | 4 | 153 | 3 | 836 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 4.59e-05 | 24 | 153 | 4 | 615 | |
| GeneFamily | Calcium voltage-gated channel subunits | 6.38e-05 | 26 | 153 | 4 | 253 | |
| GeneFamily | WD repeat domain containing | IFT172 HIRA WRAP73 WDR35 CORO7 APAF1 TEP1 WDR11 IFT122 WDFY3 | 8.03e-05 | 262 | 153 | 10 | 362 |
| GeneFamily | Sterile alpha motif domain containing | 9.05e-04 | 88 | 153 | 5 | 760 | |
| GeneFamily | Chitinases | 1.45e-03 | 7 | 153 | 2 | 816 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 2.24e-03 | 31 | 153 | 3 | 81 | |
| GeneFamily | Glycosyltransferase family 8 | 2.46e-03 | 9 | 153 | 2 | 436 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.96e-03 | 115 | 153 | 5 | 769 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 4.44e-03 | 12 | 153 | 2 | 737 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 NEFH USP17L17 USP17L3 USP17L13 NDUFB11 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 STK31 USP17L6P USP17L22 USP17L15 USP17L8 | 2.20e-24 | 86 | 240 | 21 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L20 GBE1 USP17L19 USP17L18 PHEX USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.39e-20 | 112 | 240 | 20 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.30e-15 | 160 | 240 | 18 | MM1155 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L20 TNIP3 USP17L19 USP17L18 USP17L17 USP17L3 HOOK2 USP17L13 GPD2 RANBP10 USP17L4 USP17L2 USP17L12 USP17L11 APAF1 DYRK1A USP17L5 USP17L10 FOXJ3 PIKFYVE CNOT6L INTS13 SIPA1L1 USP17L6P USP17L22 HERC4 USP17L15 USP17L8 | 5.82e-08 | 1072 | 240 | 30 | MM1031 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 PITPNM2 PRKD2 USP17L4 USP17L2 USP17L12 USP17L11 APAF1 USP17L5 USP17L10 USP17L6P MAPK9 USP17L22 USP17L15 USP17L8 | 1.51e-07 | 647 | 240 | 22 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 USP17L21 COPZ2 MYO5A USP17L20 USP17L19 USP17L18 GHR USP17L17 USP17L3 CZIB HOOK2 HERC6 USP17L13 USP17L4 USP17L2 USP17L12 TNC USP17L11 DYRK1A USP17L5 USP17L10 RUFY1 CDC14B PIKFYVE AIFM1 INTS13 USP17L6P USP17L22 USP17L15 USP17L8 | 1.95e-07 | 1198 | 240 | 31 | MM1062 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L21 MYO5A USP17L20 MR1 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 PITPNM2 PRKD2 USP17L4 USP17L2 USP17L12 USP17L11 APAF1 USP17L5 USP17L10 TAMALIN MARK4 USP17L6P HAS2 MAPK9 USP17L22 USP17L15 USP17L8 | 2.40e-05 | 1226 | 240 | 27 | MM979 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 4.47e-07 | 90 | 223 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | EPHB2 BOC GLT8D1 DIS3L LRRTM1 NEB HNRNPA2B1 BDH1 PRDM9 TOX3 ASPM CACNA1A TAS1R3 ZFP30 DNAH2 ZSWIM6 SAPCD2 NRBP2 EIF3A ZNF287 EPHA3 EPHA5 | 1.68e-06 | 654 | 223 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | EPHB2 TTC3 PLCG2 TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D KRT19 TBC1D3C TBC1D3B HAS2 | 7.91e-06 | 320 | 223 | 14 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | KCNH8 TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TNC TBC1D3C TBC1D3B | 5.34e-05 | 242 | 223 | 11 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | MYO5A PHEX STXBP3 TOX3 TAF2 GPD2 TNC APAF1 ZNF365 CNOT6L TENM1 ZFHX3 PNPLA8 ZNF287 EPHA4 EPHA5 | 6.88e-05 | 492 | 223 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | EPHB2 GLT8D1 GBE1 TMTC2 LRRTM1 NEB HNRNPA2B1 BDH1 SHC3 PRDM9 ASPM WDR35 UNC13B CACNA1A TAS1R3 ZFP30 TAMALIN NRBP2 C1orf52 EIF3A EPHA3 EPHA5 EPHB1 | 7.08e-05 | 893 | 223 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TNC TBC1D3C TBC1D3B | 8.93e-05 | 213 | 223 | 10 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TNC TBC1D3C TBC1D3B | 8.93e-05 | 213 | 223 | 10 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 NEB FREM1 RYR3 CACNA1F DNAH1 TENM1 CNTNAP4 UNC13C HYDIN EPHA5 | 4.67e-09 | 184 | 237 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 NEB FREM1 RYR3 CACNA1F DNAH1 TENM1 CNTNAP4 UNC13C HYDIN EPHA5 | 4.67e-09 | 184 | 237 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 NEB FREM1 RYR3 CACNA1F DNAH1 TENM1 CNTNAP4 UNC13C HYDIN EPHA5 | 4.67e-09 | 184 | 237 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | EPHB2 CNTNAP3B CNTNAP3 FREM1 RYR3 ASPM TENM3 TENM1 CNTNAP4 ZFHX3 | 5.27e-08 | 182 | 237 | 10 | 72e65a23cd36085bc880087d3cae92395de918a1 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.93e-07 | 173 | 237 | 9 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-07 | 174 | 237 | 9 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-07 | 177 | 237 | 9 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.01e-07 | 182 | 237 | 9 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.89e-07 | 185 | 237 | 9 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.21e-07 | 186 | 237 | 9 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | BOC CNTNAP3B PTPRB PLCG2 SEC14L1 PITPNM2 PCDH11Y TMTC1 EPHA4 | 9.40e-07 | 192 | 237 | 9 | 27ff3621e177e7932dd44dd6baa81551ea75a874 |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.81e-07 | 193 | 237 | 9 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | CNTNAP3B PTPRB SEC14L1 PITPNM2 SYNE1 TAMALIN TMTC1 CNOT6L EPHA4 | 1.07e-06 | 195 | 237 | 9 | 50a193475db1bb1e05b8590225a553688c372c14 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-06 | 198 | 237 | 9 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.87e-06 | 171 | 237 | 8 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-06 | 178 | 237 | 8 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.65e-06 | 180 | 237 | 8 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.65e-06 | 180 | 237 | 8 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.88e-06 | 181 | 237 | 8 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.38e-06 | 183 | 237 | 8 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.64e-06 | 184 | 237 | 8 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.91e-06 | 185 | 237 | 8 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 6.91e-06 | 185 | 237 | 8 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.47e-06 | 187 | 237 | 8 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.39e-06 | 190 | 237 | 8 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.39e-06 | 190 | 237 | 8 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.39e-06 | 190 | 237 | 8 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.39e-06 | 190 | 237 | 8 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.39e-06 | 190 | 237 | 8 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.72e-06 | 191 | 237 | 8 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-06 | 192 | 237 | 8 | b18ae7337eaad1315a5b0ee81c75f7606bd3c7fe | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-06 | 192 | 237 | 8 | b2d9cc2a013012b25b458d4dc77be63e1c2144da | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.77e-06 | 194 | 237 | 8 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.01e-05 | 195 | 237 | 8 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-05 | 196 | 237 | 8 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.09e-05 | 197 | 237 | 8 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 1.09e-05 | 197 | 237 | 8 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-05 | 199 | 237 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.22e-05 | 200 | 237 | 8 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 237 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.22e-05 | 200 | 237 | 8 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 237 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 237 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 237 | 8 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 151 | 237 | 7 | 79827a76c675dcb82f59c0a45d0f962b02d5bfd6 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 1.98e-05 | 155 | 237 | 7 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 160 | 237 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 160 | 237 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.07e-05 | 166 | 237 | 7 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.19e-05 | 167 | 237 | 7 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-05 | 168 | 237 | 7 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.44e-05 | 169 | 237 | 7 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 169 | 237 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.71e-05 | 171 | 237 | 7 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.85e-05 | 172 | 237 | 7 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.85e-05 | 172 | 237 | 7 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 172 | 237 | 7 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.14e-05 | 174 | 237 | 7 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 4.30e-05 | 175 | 237 | 7 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 4.30e-05 | 175 | 237 | 7 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-05 | 175 | 237 | 7 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.45e-05 | 176 | 237 | 7 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.96e-05 | 179 | 237 | 7 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.32e-05 | 181 | 237 | 7 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-05 | 181 | 237 | 7 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 183 | 237 | 7 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.90e-05 | 184 | 237 | 7 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.32e-05 | 186 | 237 | 7 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | NS-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.32e-05 | 186 | 237 | 7 | c28f62524637c7eb9c43c9ec38fb12dfec6f5566 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.32e-05 | 186 | 237 | 7 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.75e-05 | 188 | 237 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.98e-05 | 189 | 237 | 7 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.98e-05 | 189 | 237 | 7 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.22e-05 | 190 | 237 | 7 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.22e-05 | 190 | 237 | 7 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.22e-05 | 190 | 237 | 7 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.24e-05 | 131 | 237 | 6 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.46e-05 | 191 | 237 | 7 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.71e-05 | 192 | 237 | 7 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.71e-05 | 192 | 237 | 7 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-05 | 192 | 237 | 7 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.96e-05 | 193 | 237 | 7 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.96e-05 | 193 | 237 | 7 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.96e-05 | 193 | 237 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.96e-05 | 193 | 237 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.96e-05 | 193 | 237 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.22e-05 | 194 | 237 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 8.22e-05 | 194 | 237 | 7 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.22e-05 | 194 | 237 | 7 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.77e-05 | 196 | 237 | 7 | e4c76e7ad68455e51fe93ce588bcec9383f8654b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 196 | 237 | 7 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 196 | 237 | 7 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 196 | 237 | 7 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 8.77e-05 | 196 | 237 | 7 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 9.34e-05 | 198 | 237 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-05 | 198 | 237 | 7 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-05 | 198 | 237 | 7 | 451003a21162eeae90739fdb502bb50b362d80c8 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.34e-05 | 198 | 237 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.64e-05 | 199 | 237 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.64e-05 | 199 | 237 | 7 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.55e-28 | 46 | 231 | 19 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.47e-24 | 69 | 231 | 19 | DOID:1682 (implicated_via_orthology) |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.62e-05 | 7 | 231 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.58e-05 | 8 | 231 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | oxoglutarate dehydrogenase deficiency (implicated_via_orthology) | 6.10e-05 | 2 | 231 | 2 | DOID:0081326 (implicated_via_orthology) | |
| Disease | Amyotrophic Lateral Sclerosis | 9.20e-05 | 58 | 231 | 5 | C0002736 | |
| Disease | Short Rib-Polydactyly Syndrome | 1.28e-04 | 13 | 231 | 3 | C0036996 | |
| Disease | Saldino-Noonan Syndrome | 1.62e-04 | 14 | 231 | 3 | C0036069 | |
| Disease | Majewski Syndrome | 1.62e-04 | 14 | 231 | 3 | C0024507 | |
| Disease | level of alpha-N-acetylglucosaminidase in blood serum | 1.82e-04 | 3 | 231 | 2 | OBA_2042500 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.82e-04 | 3 | 231 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | Synostotic Posterior Plagiocephaly | 2.46e-04 | 16 | 231 | 3 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 2.46e-04 | 16 | 231 | 3 | C4551902 | |
| Disease | Acrocephaly | 2.46e-04 | 16 | 231 | 3 | C0030044 | |
| Disease | Trigonocephaly | 2.46e-04 | 16 | 231 | 3 | C0265535 | |
| Disease | Scaphycephaly | 2.46e-04 | 16 | 231 | 3 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 2.46e-04 | 16 | 231 | 3 | C2931150 | |
| Disease | Metopic synostosis | 2.46e-04 | 16 | 231 | 3 | C1860819 | |
| Disease | Eye Abnormalities | 2.97e-04 | 17 | 231 | 3 | C0015393 | |
| Disease | Brachycephaly | 2.97e-04 | 17 | 231 | 3 | C0221356 | |
| Disease | migraine (implicated_via_orthology) | 3.62e-04 | 4 | 231 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 3.62e-04 | 4 | 231 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Cranioectodermal dysplasia | 3.62e-04 | 4 | 231 | 2 | cv:C4551571 | |
| Disease | glioblastoma (is_marker_for) | 3.89e-04 | 44 | 231 | 4 | DOID:3068 (is_marker_for) | |
| Disease | oropharynx cancer | 4.61e-04 | 46 | 231 | 4 | EFO_1001931 | |
| Disease | Craniosynostosis | 4.89e-04 | 20 | 231 | 3 | C0010278 | |
| Disease | HbA1c measurement, response to sulfonylurea | 5.68e-04 | 21 | 231 | 3 | EFO_0004541, EFO_0007922 | |
| Disease | odorant-binding protein 2b measurement | 6.01e-04 | 5 | 231 | 2 | EFO_0801859 | |
| Disease | CRANIOECTODERMAL DYSPLASIA 1 | 6.01e-04 | 5 | 231 | 2 | C0432235 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 8.49e-04 | 24 | 231 | 3 | DOID:3827 (biomarker_via_orthology) | |
| Disease | Cerebral ventriculomegaly | 1.25e-03 | 7 | 231 | 2 | C1531647 | |
| Disease | Hereditary Autoinflammatory Diseases | 1.25e-03 | 7 | 231 | 2 | C0751422 | |
| Disease | Hydrocephalus Ex-Vacuo | 1.25e-03 | 7 | 231 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 1.25e-03 | 7 | 231 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 1.25e-03 | 7 | 231 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 1.25e-03 | 7 | 231 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 1.25e-03 | 7 | 231 | 2 | C0549423 | |
| Disease | Congenital Hydrocephalus | 1.66e-03 | 8 | 231 | 2 | C0020256 | |
| Disease | Aqueductal Stenosis | 1.66e-03 | 8 | 231 | 2 | C2936786 | |
| Disease | epilepsy (implicated_via_orthology) | 1.85e-03 | 163 | 231 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Large cell carcinoma of lung | 1.99e-03 | 32 | 231 | 3 | C0345958 | |
| Disease | Squamous cell carcinoma of lung | 1.99e-03 | 32 | 231 | 3 | C0149782 | |
| Disease | plasma renin activity measurement | 2.12e-03 | 9 | 231 | 2 | EFO_0006828 | |
| Disease | Hydrocephalus | 2.12e-03 | 9 | 231 | 2 | C0020255 | |
| Disease | Retinal Pigment Epithelial Detachment | 2.12e-03 | 9 | 231 | 2 | C0339546 | |
| Disease | Drug habituation | 2.15e-03 | 115 | 231 | 5 | C0013170 | |
| Disease | Drug abuse | 2.15e-03 | 115 | 231 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.15e-03 | 115 | 231 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 2.15e-03 | 115 | 231 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 2.15e-03 | 115 | 231 | 5 | C0013222 | |
| Disease | Drug Dependence | 2.15e-03 | 115 | 231 | 5 | C1510472 | |
| Disease | Substance Dependence | 2.15e-03 | 115 | 231 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 2.15e-03 | 115 | 231 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.15e-03 | 115 | 231 | 5 | C0029231 | |
| Disease | Substance abuse problem | 2.23e-03 | 116 | 231 | 5 | C0740858 | |
| Disease | Polydactyly | 2.32e-03 | 117 | 231 | 5 | C0152427 | |
| Disease | Autoinflammatory disorder | 2.58e-03 | 35 | 231 | 3 | C3860213 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.63e-03 | 10 | 231 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | endometrial hyperplasia (is_marker_for) | 2.63e-03 | 10 | 231 | 2 | DOID:0080365 (is_marker_for) | |
| Disease | brain volume measurement | EPHB2 MR1 PTK2 CACNA1A MRC1 PRKD2 ZSWIM6 ATE1 CNOT6L ZFHX3 EPHA3 AFG1L | 2.71e-03 | 595 | 231 | 12 | EFO_0006930 |
| Disease | Retinal Detachment | 3.20e-03 | 11 | 231 | 2 | C0035305 | |
| Disease | Jeune thoracic dystrophy | 3.20e-03 | 11 | 231 | 2 | C0265275 | |
| Disease | verbal-numerical reasoning measurement | 3.77e-03 | 131 | 231 | 5 | EFO_0008394 | |
| Disease | Cleft Palate | 3.80e-03 | 81 | 231 | 4 | C0008925 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.82e-03 | 12 | 231 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 3.82e-03 | 12 | 231 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 3.82e-03 | 12 | 231 | 2 | C0270960 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 4.52e-03 | 85 | 231 | 4 | EFO_0000708, EFO_0006953 | |
| Disease | systemic scleroderma | 4.52e-03 | 85 | 231 | 4 | EFO_0000717 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 5.11e-03 | 88 | 231 | 4 | EFO_0803332 | |
| Disease | memory performance | 5.17e-03 | 409 | 231 | 9 | EFO_0004874 | |
| Disease | Primary Ciliary Dyskinesia | 5.96e-03 | 47 | 231 | 3 | C4551720 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 6.20e-03 | 93 | 231 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | neuritic plaque measurement | 6.48e-03 | 349 | 231 | 8 | EFO_0006798 | |
| Disease | Tremor, Rubral | 6.81e-03 | 16 | 231 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 6.81e-03 | 16 | 231 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 6.81e-03 | 16 | 231 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 6.81e-03 | 16 | 231 | 2 | C0240991 | |
| Disease | Alpha ketoglutarate measurement | 6.81e-03 | 16 | 231 | 2 | EFO_0010457 | |
| Disease | Abnormal coordination | 6.81e-03 | 16 | 231 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 6.81e-03 | 16 | 231 | 2 | C0427190 | |
| Disease | response to haloperidol | 6.81e-03 | 16 | 231 | 2 | GO_1905119 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.03e-03 | 152 | 231 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cognitive function measurement, self reported educational attainment | 7.15e-03 | 355 | 231 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | sitting height ratio | 7.48e-03 | 51 | 231 | 3 | EFO_0007118 | |
| Disease | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement | 7.68e-03 | 17 | 231 | 2 | EFO_0010543, EFO_0010544 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVRTLSGEMDVWYNL | 771 | Q9UPW8 | |
| SGEMDVWYNLDKRTD | 776 | Q9UPW8 | |
| KDRDWGQNALYNMIE | 1051 | Q7Z4L5 | |
| ERELNGYMEWISKAE | 386 | O00555 | |
| QEVDNGMLYLEWINK | 586 | O14727 | |
| SQGVARWYDLMDNKD | 1086 | Q9BSJ8 | |
| LYRDGEDWESKQMPQ | 66 | Q6UXE8 | |
| EDWESKQMPQYRGRT | 71 | Q6UXE8 | |
| NKYQWLQIDLGERME | 76 | Q9BZ76 | |
| EYDGNIRQATVKWAM | 4726 | Q9NR09 | |
| EWVLMELQGEIEARY | 16 | P0CG13 | |
| NGYRAWIDKAEEVML | 381 | Q15878 | |
| YKQVAEVNLWGTVRM | 161 | Q02338 | |
| EYLSNWTMEKVRREG | 346 | O95831 | |
| VMKQTNLWLEGDYFR | 361 | O60729 | |
| ENWIQKYDTEMGEKQ | 331 | Q96DY2 | |
| DYMSNLRRDKWVVEG | 1236 | Q9UIF8 | |
| NVEKRWLLENMDGAF | 141 | Q9P299 | |
| ERPYWEMTNQDVIKA | 876 | P54756 | |
| LQEMLREVGLDVEYW | 21 | Q7Z2Y8 | |
| EMQTEQYWNEGDRTK | 466 | Q8WV93 | |
| NKYQWLQIDLGERME | 76 | Q9C0A0 | |
| NQWVGYDDVKSMETK | 331 | Q15782 | |
| NGEKWMDRYEIDSLI | 151 | Q13627 | |
| ELDMAIKWSNIYEDN | 121 | Q8N6N3 | |
| WAINRKLMEYPAEEN | 166 | Q9H1Y0 | |
| YSGDAVAKQQTEEMW | 361 | Q01459 | |
| FEQYSENIKLLMDWV | 1106 | Q8IZT6 | |
| FWMTRQEYQEKGVRV | 371 | P61160 | |
| ESIYNRINNDLLMWE | 831 | Q2TAZ0 | |
| NEVVYSLMAELGWRK | 451 | P54802 | |
| QQYKVLIGNREWMIR | 1176 | Q04656 | |
| IEDYMREWRAKVQGT | 226 | Q6VN20 | |
| KGPKRDEQYRIMWNE | 521 | Q9NVM9 | |
| MEREGPKYWDRNTQI | 76 | P01893 | |
| QMEEDLRGYLDWITQ | 396 | O60840 | |
| VDDWLSAIKMVQYRD | 916 | P54762 | |
| IYKEVMDWEERSKNG | 356 | P45984 | |
| ETQRPYEEALLQKMW | 276 | Q9NUD7 | |
| MTEAAGLQNYRWKLV | 271 | P23467 | |
| LYWAVEKGNATMVRD | 306 | Q9ULH0 | |
| YEVMAEQNRKDAEAW | 256 | P08727 | |
| GMSELQWEQAQDYLK | 26 | P09237 | |
| LQWRYSEVSFMELDK | 356 | Q9NSY0 | |
| LMGRELNWDDYKKQE | 576 | P43304 | |
| GVKEREWQMESLIRY | 461 | Q9HBG6 | |
| TEEEIWKFMNVLGAY | 216 | P43366 | |
| MRQSKEGEEVYSWSE | 1131 | Q8N201 | |
| GLQSELQYKADLAWM | 676 | Q86VF7 | |
| QSDNQYRADVKWMKG | 921 | Q86VF7 | |
| RDYMAEGLIFNWKQD | 261 | Q8NCE2 | |
| DVDVGDLQMVKFIWY | 406 | P16233 | |
| WNLEKMDLSGNEIEY | 256 | Q86UE6 | |
| REQEEKLLISAWYNM | 656 | Q96ED9 | |
| TQIMDQKEGSLRDWY | 706 | O60318 | |
| VGDWLQAIKMDRYKD | 916 | P54764 | |
| GFNQMREREVKLWDT | 231 | P57737 | |
| NTVDEWLEAIKMGQY | 916 | P29323 | |
| EYWLGNDKISQLTRM | 321 | P02675 | |
| EEIQDVSGTWYLKAM | 26 | Q5VSP4 | |
| INWLDRNQMAEKDEY | 581 | P54652 | |
| KGNSYMIQRKEWDLS | 221 | P26006 | |
| ITALGEKLNDYWNEM | 371 | Q14149 | |
| DMTKNRTVDWALAEY | 631 | Q9ULD0 | |
| LQKLFEMDAQGRVWS | 51 | Q8TE67 | |
| ELQAMVIGNTNYDWK | 936 | Q5GLZ8 | |
| TKMWNIAITYDGLEE | 1806 | Q5H8C1 | |
| YFKNDMTTVRLQWGD | 286 | Q4G148 | |
| LMTAIIGNTDYDWKQ | 896 | Q8IVU3 | |
| NDMVWKYNIVTLDRL | 851 | Q9ULK4 | |
| QALEKELGRYMWINQ | 1191 | Q2M1P5 | |
| GQDMKWIEEKQALYR | 561 | Q5VZ66 | |
| RVVMNSREYGAWKQQ | 61 | Q05315 | |
| EVLLNQGYNRSLDMW | 721 | Q9BZL6 | |
| EEIQDVSGTWYLKAM | 26 | P31025 | |
| QDKVDLRGYTVWSAM | 1781 | P09848 | |
| DKQLYWIDSRQNMIR | 976 | O75581 | |
| EEKQWQLDQELRGYM | 1001 | Q8TDZ2 | |
| QLEKWMKLNVEEGLY | 261 | Q68CQ7 | |
| KQQGELYMWDSIDQK | 476 | P16885 | |
| GAMENWDLVTYRETA | 316 | A6NEC2 | |
| QDEWYGLSMENIREL | 231 | Q9BZ72 | |
| YAENLKGESAMWRQR | 396 | Q08379 | |
| KWGEYRSLMVQEQRL | 211 | Q7Z6J2 | |
| FYILEQQRVGWALDM | 931 | Q3BBV0 | |
| KMDDPTVNWSNERYE | 221 | P15170 | |
| TKDAIDMYTQAGRWE | 941 | Q9UG01 | |
| AEMGDWEKTRYRNVK | 41 | Q9NQV7 | |
| MGDWKVYISAVLRDQ | 1 | P60673 | |
| TWYVGKINRTQAEEM | 621 | O00459 | |
| WEMAAQLREYQDLLN | 376 | P12036 | |
| VKNRTVDWALAEYMA | 646 | Q02218 | |
| IMEGKSQDSDLKQYW | 141 | Q9Y2I7 | |
| ELSKNYGMSEWRDDV | 2611 | Q9P2D7 | |
| AYEWEKAGRSDRVQM | 2101 | Q13535 | |
| KDEDWNMGDIVYTLT | 451 | Q04446 | |
| DVQNILMYWDRKQGV | 2466 | Q4G0P3 | |
| KQEWLEASRGNYLIM | 166 | Q9BWV1 | |
| KSAYEEQRIKDMDLW | 711 | Q14152 | |
| ADIQKGWMVLEYELQ | 181 | P10912 | |
| KQQLDEDLRGYMSWI | 356 | Q13698 | |
| GVSNDWYATLDMLKE | 451 | Q9UPW0 | |
| RNQVRLAEVWMDSYK | 426 | Q8NCL4 | |
| RGESMEKWQTRSIYN | 131 | Q8TF46 | |
| FGRYSSQRMKDWQEI | 86 | Q96JB5 | |
| MTIFEKENFIGRQWE | 126 | P05813 | |
| RLWKYALDMQQSNLE | 411 | Q9BSK4 | |
| EVMGRDKSATYIWKN | 136 | Q92819 | |
| AERMNLVGQDEIWKY | 11 | Q9H1P6 | |
| IESNDRWVQMRTAYK | 111 | P0DN25 | |
| GERPYWEMSNQDVIK | 821 | P29320 | |
| QNILEVEKEMYGAEW | 71 | Q9NZD2 | |
| IYRLMKKENNNRWGE | 721 | Q8TF76 | |
| MNRTENWIGSQYKKV | 771 | Q6MZM0 | |
| LEQIMKDKWINIGYE | 301 | Q96L34 | |
| SMTVQDYQDLIDRGW | 41 | O95260 | |
| YNMETGRWKKINTEG | 71 | Q9Y2U9 | |
| AQAMVDIVKALGWNY | 206 | Q14831 | |
| QIWQLLMTADRKDYE | 166 | Q86VF2 | |
| RLQMEAKLWGEEYNR | 186 | O00418 | |
| MGVWLNKDDYIRDLK | 1 | Q8IXB1 | |
| RLDDYGKKVMQVWTE | 2196 | A6NE01 | |
| QIIEREGWKTNMDFV | 251 | P54198 | |
| EIMENYNIALRWTAK | 271 | Q03591 | |
| MNEIWLRCDNEKQYA | 451 | Q96AC1 | |
| DWDLIYVGRKRMQVE | 461 | Q8NBJ5 | |
| VQRQWMYLENIFLGE | 1446 | Q9P225 | |
| DKVWQLGRDYSMVES | 596 | Q92503 | |
| DWNQRAMDLYKALGA | 131 | Q96F10 | |
| CGEISDKWQYIRLMD | 36 | Q9NWV4 | |
| YDKDPVLDVWNMRLV | 76 | Q9NX14 | |
| NKYQWLQIDLGERME | 76 | Q96NU0 | |
| WEKQDRVYPELQRFM | 551 | Q5VW36 | |
| IDLEEQTMGKYNWVT | 941 | Q9BZA8 | |
| WMKNGEEIVQEIDYG | 236 | Q95460 | |
| LNDIKIQMYFEWSDG | 426 | P22897 | |
| FYDSQTWENILKDRM | 531 | Q9NP80 | |
| RTEKMAVDQDWPSVY | 56 | P82673 | |
| SWQDLKDYMRQAGEV | 116 | Q08170 | |
| EAVEEATWKLQMIYG | 191 | Q68CJ6 | |
| KVDGQLLLMAVYRWD | 271 | Q5T4F7 | |
| MTRDEYNALPAWKQV | 2191 | O95425 | |
| SMLEEVISNWDRYGN | 606 | Q8NF91 | |
| LNGRWRELFMEVKQY | 686 | Q8NF91 | |
| WQRGRVMEKKNELYT | 76 | B5MCY1 | |
| DRSYEELQWLLNMIQ | 901 | Q6P1X5 | |
| QTRQGLDEMYSDVWK | 391 | Q96T51 | |
| WEMRGNALEKKSNYE | 181 | Q05397 | |
| VGSRWAMDQAKYNLI | 231 | Q7LGA3 | |
| AEMGDWEKTRYRNVK | 41 | Q9NQW5 | |
| RKEDEGWYLMTLEKN | 111 | Q13291 | |
| GWYLMTLEKNVSVQR | 116 | Q13291 | |
| AETWYQGEMSRKEAE | 496 | Q92529 | |
| MGAIVWAVRAEDYNK | 856 | O43166 | |
| VTFIQRGTWNEKMEY | 1851 | Q9UKZ4 | |
| EVTEFGNKYWLMLNE | 201 | Q9H7Z7 | |
| AMYKRGLVQVWSLEQ | 66 | Q9P2S5 | |
| WAQEREDIIMKYEKG | 11 | B9A6J9 | |
| KIENESDMIRNWSYL | 431 | O00186 | |
| AERAWSYAMQLKQEA | 131 | Q9UHB9 | |
| WQDLKDFMRQAGEVT | 121 | Q13243 | |
| QYKNKRLSGMEEWIE | 501 | O43868 | |
| ESEKHQDILMWNYRD | 201 | Q9NY97 | |
| TSGNWEELVKYLQMA | 1146 | Q00610 | |
| NWEYRKKGIMEEIVN | 216 | Q96LI5 | |
| QWKDDEGNYKTVLML | 101 | Q9H7R5 | |
| DGKLWNLNNYRTDMI | 1461 | Q6P2Q9 | |
| REEYEMLTSLAQKWF | 686 | Q9BXU1 | |
| WAQEREDIIMKYEKG | 11 | A6NDS4 | |
| WAQEREDIIMKYEKG | 11 | P0C7X1 | |
| QLYATDAWGKQLEML | 81 | Q9BZM4 | |
| AQEGQWYKMDDAEVT | 341 | A6NCW0 | |
| SSGNVDMEYDLKLWV | 446 | Q7RTX0 | |
| MREIVDKYFPDNWVI | 276 | Q12768 | |
| QGKDIYEMNLSQWKV | 91 | Q9Y2G7 | |
| LDPSQKNLYRDVMWE | 21 | P52737 | |
| QWRGEQEKMLKDYLS | 91 | Q6AWC2 | |
| QEDWELMRPVQKELY | 181 | Q9HBT7 | |
| MQQKAFEESRYPWQE | 1 | Q70YC5 | |
| QRWERGEISNFQYLM | 2696 | Q8IZQ1 | |
| RSLGENSMAEEWYKR | 661 | Q8IUR5 | |
| NSMAEEWYKRALQVA | 666 | Q8IUR5 | |
| AQEGQWYKMDDAEVT | 341 | A6NCW7 | |
| VRTLSGEMDVWYNLE | 1316 | Q8NB66 | |
| GEMDVWYNLEKRTDK | 1321 | Q8NB66 | |
| DGMINVAKQLYWQRV | 791 | Q99973 | |
| QWDQQFRSMKELYER | 56 | Q96KP6 | |
| ALLTKWQRIMGINYE | 536 | O75970 | |
| LSGYTDEKNSLWREM | 561 | Q9NXC5 | |
| YEQWGKLTDCVVMRD | 41 | P22626 | |
| YMWGVQDTDLVLRKA | 111 | P21580 | |
| SILGYLELRNMEWKN | 511 | A0A1B0GUW6 | |
| EAMRWFQQKYDGIIL | 161 | P62913 | |
| LEMMARGRDWYQQQL | 246 | Q86UD0 | |
| WAQEREDIIMKYEKG | 11 | A6NER0 | |
| RWNEKRAMFGVYDNI | 46 | Q4U2R6 | |
| VLVNMVYFKGQWDRE | 176 | Q9UIV8 | |
| DMTGARIAYKNWETE | 146 | P05452 | |
| DLELINKWAFQGERM | 181 | Q03426 | |
| IDEASWMKRIAVYAQ | 3186 | Q15413 | |
| DIQMELQGSELWKRF | 91 | Q9Y458 | |
| LFYRDTEQVDNWMSK | 471 | Q13813 | |
| AIRNGDWQNEEMLYR | 471 | Q8N394 | |
| DWQNEEMLYRSGIKV | 476 | Q8N394 | |
| AQEGQWYKMDDAEVT | 341 | D6R9N7 | |
| TWEIIFRNMNKEDEG | 741 | P24821 | |
| AQEGQWYKMDDAEVT | 341 | A8MUK1 | |
| AQEGQWYKMDDAEVT | 341 | D6R901 | |
| MLGEYDWALQANIKA | 311 | P53804 | |
| AQEGQWYKMDDAEVT | 341 | C9JLJ4 | |
| GVRWAFIDMLEKENE | 441 | P78562 | |
| WITIQYDNMGRVTKR | 2101 | Q9P273 | |
| GQLQTVYLNEKIMWR | 2136 | Q9P273 | |
| AQEGQWYKMDDAEVT | 341 | D6RCP7 | |
| VRTLSGEMDVWYNLE | 696 | O14795 | |
| GEMDVWYNLEKRTDK | 701 | O14795 | |
| WAQEREDIIMKYEKG | 11 | A0A087X179 | |
| MNRTKGDEEEYWNSS | 1 | Q9H9C1 | |
| SMWDSLGEEQKQVYK | 291 | O15405 | |
| AQEGQWYKMDDAEVT | 341 | C9JPN9 | |
| KENGIQDMEQFYELW | 806 | Q8IWR0 | |
| YWKEKRQNDMIDGEV | 361 | A0A3B3IT33 | |
| WRQQGTAMTDKYRQL | 426 | Q9HCJ5 | |
| TAMTDKYRQLWDELG | 431 | Q9HCJ5 | |
| AQEGQWYKMDDAEVT | 341 | Q0WX57 | |
| ENLEDWQKELYRNVM | 156 | Q9UDV6 | |
| AQEGQWYKMDDAEVT | 341 | P0C7H9 | |
| AQEGQWYKMDDAEVT | 341 | P0C7I0 | |
| RNSEISKQLGYQWKM | 86 | Q05066 | |
| WAQEREDIIMKYEKG | 11 | A0A087WVF3 | |
| FQWDIMERIKSYSLQ | 101 | Q9HCL3 | |
| RQLDSTQKEQYWDLM | 226 | P17022 | |
| AQEGQWYKMDDAEVT | 341 | Q6QN14 | |
| WYERNEVEIVMSLLG | 466 | Q8TDI7 | |
| ETLAWEGVMKENYLV | 1051 | Q7Z2W7 | |
| LIAMYNDGAEVWDTK | 766 | Q9BZH6 | |
| AQEGQWYKMDDAEVT | 341 | D6RA61 | |
| YKGSWIEEMINNRNK | 101 | Q9P2L0 | |
| WAQEREDIIMKYEKG | 11 | Q6DHY5 | |
| WAQEREDIIMKYEKG | 11 | Q8IZP1 | |
| AQEGQWYKMDDAEVT | 341 | C9J2P7 | |
| AQEGQWYKMDDAEVT | 341 | D6RBQ6 | |
| EIYEMESLQWENMGK | 61 | Q7Z3V5 | |
| WAQEREDIIMKYEKG | 11 | A0A087X1G2 | |
| IKEEDMRLWLYNSEN | 661 | Q8NFA0 | |
| MLVKAWNVDELQAYA | 511 | Q6NUM6 | |
| AQEGQWYKMDDAKVT | 341 | Q6R6M4 | |
| WAQEREDIIMKYEKG | 11 | A0A087WXS9 | |
| WAQEREDIIMKYEKG | 11 | Q6IPX1 | |
| AQEGQWYKMDDAEVT | 341 | D6RJB6 | |
| FAEVSDLKGMVQRWQ | 296 | Q9Y2L8 | |
| AQEGQWYKMDDAEVT | 341 | C9JJH3 | |
| LSEDEWKAVMGDSYQ | 971 | Q15911 | |
| AQEGQWYKMDDAEVT | 341 | C9JVI0 | |
| QGKMNETPTEWLRYN | 981 | Q7Z570 | |
| ACIWYVIGKMEREDN | 371 | Q96L42 | |
| GMQIRYNVSQLEEWL | 1716 | Q9Y4I1 | |
| QITMSDKLYKAGWEE | 1776 | P20929 | |
| NMNKRLYTEAWDNDK | 3446 | P20929 | |
| LNVSNKLYREGWDEM | 3966 | P20929 |